Cargando…
The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. The extracellular deposits of Amyloid beta (Aβ) in the brain—called amyloid plaques, and neurofibrillary tangles—intracellular tau aggregates, are morphological hallmarks of the disease. The risk for AD is a complicated interplay b...
Autores principales: | Wolfe, Cody M., Fitz, Nicholas F., Nam, Kyong Nyon, Lefterov, Iliya, Koldamova, Radosveta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337314/ https://www.ncbi.nlm.nih.gov/pubmed/30587772 http://dx.doi.org/10.3390/ijms20010081 |
Ejemplares similares
-
Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
por: Fitz, Nicholas F., et al.
Publicado: (2020) -
ABCA1 haplodeficiency affects the brain transcriptome following traumatic brain injury in mice expressing human APOE isoforms
por: Castranio, Emilie L., et al.
Publicado: (2018) -
APOEε4 and risk of Alzheimer’s disease – time to move forward
por: Lefterov, Iliya, et al.
Publicado: (2023) -
RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers
por: Nam, Kyong Nyon, et al.
Publicado: (2016) -
Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice
por: Carter, Alexis Y., et al.
Publicado: (2017)